Form 4: Pfizer Executive Vice President Michael McDermott Reports Stock Transactions

Executive Vice President Michael McDermott reports the earn-out of stock appreciation rights and withholding of shares for tax obligations and exercise price payments.

Summary

• Michael McDermott, an Executive Vice President at Pfizer Inc., reported several transactions involving Pfizer common stock.
• On February 23, 2024, McDermott earned out 12,412 stock appreciation rights at a price of $27.34.
• Also on February 23, 2024, shares were withheld to satisfy tax obligations (859 shares at $27.76) and to cover the exercise price (10,031 shares at $27.37).
• On February 25 and 26, 2024, additional shares were withheld to satisfy tax obligations upon the vesting of restricted stock units (2,992 shares at $27.76 and 6,063 shares at $27.18 respectively).
• Following these transactions, McDermott directly owns 75,463 shares of Pfizer common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the number of shares held by a company executive.

Key Dates